For citations:
Vasilyuk V.B., Faraponova M.V., Syraeva G.I., Verveda A.B., Belskaya A.V., Shults A.V., Kubarskaya L.G., Zolotoverkhaya E.A. Comparative evaluation of safety parameters at the preclinical and clinical stages of the study of the Reamberin® (LLC "POLYSAN"). Pharmacokinetics and Pharmacodynamics. 2022;(3):52-61. (In Russ.) https://doi.org/10.37489/2587-7836-2022-3-52-61